Hypermethylated Promoters of Secreted Frizzled-Related Protein Genes Are Associated with Colorectal Cancer

Overview

Journal Pathol Oncol Res

Specialty Oncology

Date 2018 Oct 29

PMID 30368728

Citations 10

Authors

Haochang Hu

Tiangong Wang

Ranran Pan

Yong Yang

Bin Li

Cong Zhou

Jun Zhao

Yi Huang

Shiwei Duan

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the leading causes of death worldwide. Aberrant DNA methylation has been recognized as one of the most common molecular alterations in CRC. The goal of this study was to investigate the diagnostic value of SFRP1 and SFRP2 methylation for CRC. A total of 80 pairs of CRC patients were recruited to test the association of SFRP1 and SFRP2 promotor methylation with CRC. Methylation assay was performed using quantitative methylation-specific polymerase chain reaction (qMSP) method. In this study, we found the methylation levels of SFRP1 and SFRP2 in CRC tumor tissues were significantly higher than those in the adjacent non-tumor tissues (SFRP1: P = 2E-5; SFRP2: P = 0.014). Further bioinformatics analysis of TCGA data confirmed the association of the two genes with CRC (SFRP1: P = 7E-21; SFRP2: P = 5E-24). Luciferase reporter gene assay showed that the recombinant plasmids with SFRP1 and SFRP2 fragments could significantly enhance promoter activity (SFRP1: P = 0.002; SFRP2: P = 0.004). In addition, SFRP1 and SFRP2 methylation were inversely correlated with the mRNA expression displayed by TCGA data mining (SFRP1: r = -0.432, P = 4E-11; SFRP2: r = -0.478, P = 1E-13). GEO data analysis indicated that SFRP1 and SFRP2 expression were increased in three CRC cell lines (COLO320, HCT116 and HT29) after 5'-AZA-deoxycytidine treatment, suggesting that DNA methylation played an important role in regulating gene expression of the two genes. Our results confirmed that promoter methylation of SFRP1 and SFRP2 contributed to the risk of CRC.

Citing Articles

SFRP2 mediates Epstein-Barr virus and bladder cancer risk: a Mendelian randomization study and colocalization analysis.

Li J, Yang B, Guo L, Huang W, Hu Q, Yan H Sci Rep. 2025; 15(1):7118.

PMID: 40016549 PMC: 11868617. DOI: 10.1038/s41598-025-91594-9.

Hypermethylation of the sodium channel beta subunit gene promoter is associated with colorectal cancer.

Liu Y, Duan Y, Bai T, Kong D Hereditas. 2024; 161(1):39.

PMID: 39415304 PMC: 11484387. DOI: 10.1186/s41065-024-00340-0.

Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.

Boughanem H, Pilo J, Garcia-Flores L, Arranz I, Ramos-Fernandez M, Ortega-Castan M J Transl Med. 2024; 22(1):509.

PMID: 38802858 PMC: 11129357. DOI: 10.1186/s12967-024-05329-x.

Modular and mechanistic changes across stages of colorectal cancer.

Rahiminejad S, Maurya M, Mukund K, Subramaniam S BMC Cancer. 2022; 22(1):436.

PMID: 35448980 PMC: 9022252. DOI: 10.1186/s12885-022-09479-3.

The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia.

Hu H, Chen R, Hu Y, Wang J, Lin S, Chen X Lipids Health Dis. 2021; 20(1):101.

PMID: 34511120 PMC: 8436568. DOI: 10.1186/s12944-021-01536-3.

References

Dashwood R . Early detection and prevention of colorectal cancer (review). Oncol Rep. 1999; 6(2):277-81. View

Caldwell G, Jones C, Gensberg K, Jan S, Hardy R, Byrd P . The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 2004; 64(3):883-8. DOI: 10.1158/0008-5472.can-03-1346. View

Chen W, Han Z, Skoletsky J, Olson J, Sah J, Myeroff L . Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst. 2005; 97(15):1124-32. DOI: 10.1093/jnci/dji204. View

Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B . Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene. 2006; 25(24):3479-88. DOI: 10.1038/sj.onc.1209386. View

Huang Z, Li L, Wang J . Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci. 2007; 52(9):2287-91. DOI: 10.1007/s10620-007-9755-y. View

Huang J, Zhang Y, Teng X, Lin Y, Zheng D, Yang P . Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma. BMC Cancer. 2007; 7:126. PMC: 1940018. DOI: 10.1186/1471-2407-7-126. View

Yamashita K, Watanabe M . Clinical significance of tumor markers and an emerging perspective on colorectal cancer. Cancer Sci. 2009; 100(2):195-9. PMC: 11158403. DOI: 10.1111/j.1349-7006.2008.01022.x. View

Takeda M, Nagasaka T, Dong-Sheng S, Nishie H, Oka T, Yamada E . Expansion of CpG methylation in the SFRP2 promoter region during colorectal tumorigenesis. Acta Med Okayama. 2011; 65(3):169-77. DOI: 10.18926/AMO/46628. View

Wang Z, Yuan X, Jiao N, Zhu H, Zhang Y, Tong J . CDH13 and FLBN3 gene methylation are associated with poor prognosis in colorectal cancer. Pathol Oncol Res. 2011; 18(2):263-70. DOI: 10.1007/s12253-011-9437-0. View

10.

Cahill N, Rosenquist R . Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics. 2013; 8(2):138-48. PMC: 3592899. DOI: 10.4161/epi.23439. View

11.

Chen C, Wang L, Liao Q, Huang Y, Ye H, Chen F . Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagn Pathol. 2013; 8:199. PMC: 4029727. DOI: 10.1186/1746-1596-8-199. View

12.

Zhang H, Zhu Y, Wu Y, Zhang P, Qi J . Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. World J Gastroenterol. 2014; 20(20):6329-35. PMC: 4033472. DOI: 10.3748/wjg.v20.i20.6329. View

13.

Huang S, Zhong X, Gao J, Song R, Wu H, Zi S . Coexpression of SFRP1 and WIF1 as a prognostic predictor of favorable outcomes in patients with colorectal carcinoma. Biomed Res Int. 2014; 2014:256723. PMC: 4053147. DOI: 10.1155/2014/256723. View

14.

Harada T, Yamamoto E, Yamano H, Nojima M, Maruyama R, Kumegawa K . Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer. Cancer Prev Res (Phila). 2014; 7(10):1002-10. DOI: 10.1158/1940-6207.CAPR-14-0162. View

15.

Piras G, Monne M, Palmas A, Calvisi A, Asproni R, Vacca F . Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma. Clin Epigenetics. 2014; 6(1):16. PMC: 4147879. DOI: 10.1186/1868-7083-6-16. View

16.

Ma D, Jiang C, Hu X, Liu H, Li Q, Li T . Methylation patterns of the IFN-γ gene in cervical cancer tissues. Sci Rep. 2014; 4:6331. PMC: 4160705. DOI: 10.1038/srep06331. View

17.

Cannas V, Daino G, Corona A, Esposito F, Tramontano E . A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β. J Infect Dis. 2015; 212 Suppl 2:S277-81. DOI: 10.1093/infdis/jiv214. View

18.

Babaei H, Mohammadi M, Salehi R . DNA methylation analysis of secreted frizzled-related protein 2 gene for the early detection of colorectal cancer in fecal DNA. Niger Med J. 2016; 57(4):242-5. PMC: 4995817. DOI: 10.4103/0300-1652.188357. View

19.

Li X, Kong L, Liao S, Lu J, Ma L, Long X . The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas. Saudi J Gastroenterol. 2017; 23(1):28-33. PMC: 5329973. DOI: 10.4103/1319-3767.199112. View

20.

Liu Y, Zhou Q, Zhou D, Huang C, Meng X, Li J . Secreted frizzled-related protein 2-mediated cancer events: Friend or foe?. Pharmacol Rep. 2017; 69(3):403-408. DOI: 10.1016/j.pharep.2017.01.001. View